These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35810259)

  • 21. Neuromedin U Suppresses Collagen-Induced Arthritis through ILC2-Th2 Activation.
    Zhang Y; Qin Y; Chen Z
    J Immunol Res; 2021; 2021():5599439. PubMed ID: 33748288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation.
    Grippi C; Izzi B; Gianfagna F; Noro F; Falcinelli E; Di Pardo A; Amico E; Donati MB; de Gaetano G; Iacoviello L; Hoylaerts MF; Cerletti C
    Thromb Res; 2017 Nov; 159():100-108. PubMed ID: 29078099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromedin U regulates the anti-tumor activity of CD8
    Zheng R; Wang S; Wang J; Zhou M; Shi Q; Liu B
    Cancer Sci; 2024 Feb; 115(2):334-346. PubMed ID: 38071753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.
    Zhang W; Sakoda H; Nakazato Y; Islam MN; Pattou F; Kerr-Conte J; Nakazato M
    PLoS One; 2021; 16(4):e0250232. PubMed ID: 33857254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.
    Hsiao YT; Manikowski KJ; Snyder S; Griffin N; Orr AL; Hulsey EQ; Born-Evers G; Zukosky T; Squire ME; Hum JM; Metzger CE; Allen MR; Lowery JW
    Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice.
    Wang F; Zhang Y; Jiang X; Zhang Y; Zhang L; Gong S; Liu C; Zhou L; Tao J
    Cell Calcium; 2011 Jan; 49(1):12-22. PubMed ID: 21106238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment.
    Przygodzka P; Soboska K; Sochacka E; Pacholczyk M; Braun M; Kassassir H; Papiewska-Pająk I; Kielbik M; Boncela J
    Cell Commun Signal; 2022 Dec; 20(1):193. PubMed ID: 36482448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.
    Botticelli L; Micioni Di Bonaventura E; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; Bonifazi A; Cifani C; Micioni Di Bonaventura MV
    Pharmacol Res; 2023 Sep; 195():106875. PubMed ID: 37517560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
    Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
    Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
    Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
    Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
    Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
    Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
    Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
    J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?
    Kaczmarek P; Malendowicz LK; Fabis M; Ziolkowska A; Pruszynska-Oszmalek E; Sassek M; Wojciechowicz T; Szczepankiewicz D; Andralojc K; Szkudelski T; Strowski MZ; Nowak KW
    Pancreas; 2009 Mar; 38(2):208-12. PubMed ID: 18948835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromedin U inhibits food intake partly by inhibiting gastric emptying.
    Dalbøge LS; Pedersen SL; Secher T; Holst B; Vrang N; Jelsing J
    Peptides; 2015 Jul; 69():56-65. PubMed ID: 25895852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of potent and proteolytically stable human neuromedin U receptor agonists.
    De Prins A; Martin C; Van Wanseele Y; Skov LJ; Tömböly C; Tourwé D; Caveliers V; Van Eeckhaut A; Holst B; Rosenkilde MM; Smolders I; Ballet S
    Eur J Med Chem; 2018 Jan; 144():887-897. PubMed ID: 29329072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
    Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
    Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation.
    Mizukawa Y; Doi T; Yamazaki Y; Kudo A; Shiohara T
    PLoS One; 2016; 11(7):e0160122. PubMed ID: 27463114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.
    Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.
    Takayama K; Mori K; Sohma Y; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
    ACS Med Chem Lett; 2015 Mar; 6(3):302-7. PubMed ID: 25815150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.
    Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M
    J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.